Kilari Deepak, Venci Nicholas, Friedberg Jonathan, Bennett John M
Division of Hematology/Oncology, University of Rochester, Wilmot Cancer Center, Rochester, NY, USA.
Department of Internal Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Leuk Res Rep. 2013 Jan 5;2(1):4-6. doi: 10.1016/j.lrr.2012.10.003. eCollection 2013.
Hemophagocytic lymphohistiocytosis (HLH) is a potentially fatal syndrome characterized by a non-malignant expansion of the macrophage population in the setting of a heightened cytokine response with subsequent widespread hemophagocytosis. It can occur as either genetic or acquired forms; the latter of which frequently occurs in the setting of infection, autoimmune disease, or malignancy. We present the second known case of HLH associated Chronic Lymphocytic Leukemia (CLL) in the absence of infectious etiology and review the current literature.
噬血细胞性淋巴组织细胞增生症(HLH)是一种潜在致命性综合征,其特征为巨噬细胞群体在细胞因子反应增强的情况下发生非恶性扩增,并随后出现广泛的噬血细胞现象。它可表现为遗传型或获得型;后者常发生于感染、自身免疫性疾病或恶性肿瘤的背景下。我们报告了第二例已知的无感染病因的HLH合并慢性淋巴细胞白血病(CLL)病例,并对当前文献进行了综述。